Psychiatry's age of enlightenment: Optogenetics and the discovery of novel targets for the treatment of psychiatric disorders

Journal of Psychiatry and Neuroscience

Volumn 37, Issue 1, 2012, Pages 4-6

  Sidor, Michelle M ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIORHODOPSIN; CATION CHANNEL; CHANNEL RHODOPSIN; ION CHANNEL; RHODOPSIN; UNCLASSIFIED DRUG;

ANXIETY DISORDER; BIPOLAR DISORDER; CHOLINERGIC NERVE CELL; DEPRESSION; EDITORIAL; GENETICS; HUMAN; LOSS OF FUNCTION MUTATION; MENTAL DISEASE; NERVE CELL; NERVE CELL MEMBRANE POTENTIAL; NEUROMODULATION; NEUROSCIENCE; NONHUMAN; OPTICS; OPTOGENETICS; VISUAL STIMULATION;

EID: 84255184248     PISSN: 11804882     EISSN: 14882434     Source Type: Journal    
DOI: 10.1503/jpn.110175     Document Type: Editorial

References (23)

1. Boyden ES, Zhang F, Bamberg E, et al. Millisecond-timescale, genetically targeted optical control of neural activity. Nat Neurosci 2005; 8:1263-8.
2. Yizhar O, Fenno LE, Davidson TJ, et al. Optogenetics in neural systems. Neuron 2011;71:9-34.
3. Deisseroth K, Feng G, Majewska AK, et al. Next-generation optical technologies for illuminating genetically targeted brain circuits. J Neurosci 2006;26:10380-6.
4. Nagel G, Szellas T, Huhn W, et al. Channelrhodopsin-2, a directly light-gated cation-selective membrane channel. Proc Natl Acad Sci U S A 2003;100:13940-5.
5. Zhang F, Wang LP, Brauner M, et al. Multimodal fast optical in-terro gation of neural circuitry. Nature 2007;446:633-9.
6. Oesterhelt D, Stoeckenius W. Rhodopsin-like protein from the purple membrane of Halobacterium halobium. Nat New Biol 1971;233: 149-52.
7. Matsuno-Yagi A, Mukohata Y. Two possible roles of bacterio-rhodopsin; a comparative study of strains of Halobacterium halobium differing in pigmentation. Biochem Biophys Res Commun 1977; 78:237-43.
8. Aravanis AM, Wang LP, Zhang F, et al. An optical neural interface: in vivo control of rodent motor cortex with integrated fiberoptic and optogenetic technology. J Neural Eng 2007;4:S143-S156.
9. Arenkiel BR, Peca J, Davison IG, et al. In vivo light-induced activation of neural circuitry in transgenic mice expressing channelrhodopsin-2. Neuron 2007;54:205-18.
10. Tsai HC, Zhang F, Adamantidis A, et al. Phasic firing in dopaminergic neurons is sufficient for behavioral conditioning. Science 2009; 324:1080-4.
11. Adamantidis AR, Tsai HC, Boutrel B, et al. Optogenetic interro-gation of dopaminergic modulation of the multiple phases of reward-seeking behavior. J Neurosci 2011;31:10829-35.
12. Tye KM, Prakash R, Kim SY, et al. Amygdala circuitry mediating reversible and bidirectional control of anxiety. Nature 2011;471: 358-62.
13. Witten IB, Lin SC, Brodsky M, et al. Cholinergic interneurons control local circuit activity and cocaine conditioning. Science 2010;330:1677-81.
14. Covington HE III, Lobo MK, Maze I, et al. Antidepressant effect of optogenetic stimulation of the medial prefrontal cortex. J Neurosci 2010; 30:16082-90.
15. Krishnan V, Berton O, Nestler E. The use of animal models in psychi atric research and treatment. Am J Psychiatry 2008;165:1109.
16. Roybal K, Theobold D, Graham A, et al. Mania-like behavior induced by disruption of CLOCK. Proc Natl Acad Sci U S A 2007;104: 6406-11.
17. Coque L, Mukherjee S, Cao JL, et al. Specific role of VTA dopamine neuronal firing rates and morphology in the reversal of anxiety-related, but not depression-related behavior in the Clock-Delta19 mouse model of mania. Neuropsychopharmacology 2011;36: 1478-88.
18. Dzirasa K, Coque L, Sidor MM, et al. Lithium ameliorates nucleus accumbens phase-signaling dysfunction in a genetic mouse model of mania. J Neurosci 2010;30:16314-23.
19. Gradinaru V, Mogri M, Thompson KR, et al. Optical deconstruction of parkinsonian neural circuitry. Science 2009;324:354-9.
20. Busskamp V, Roska B. Optogenetic approaches to restoring visual function in retinitis pigmentosa. Curr Opin Neurobiol 2011 June 25. [Epub ahead of print].
21. Diester I, Kaufman MT, Mogri M, et al. An optogenetic toolbox designed for primates. Nat Neurosci 2011;14:387-97.
22. Bernstein JG, Han X, Henninger MA, et al. Prosthetic systems for therapeutic optical activation and silencing of genetically-targeted neurons. Proc Soc Photo Opt Instrum Eng 2008;6854:68540H.
23. Desai M, Kahn I, Knoblich U, et al. Mapping brain networks in awake mice using combined optical neural control and fMRI. J Neurophysiol 2011;105:1393-405.